CAMG
GILD icon

CWA Asset Management Group’s Gilead Sciences GILD Stock Holding History

CWA Asset Management Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-500
Closed -$31K – 307
2021
Q4 		$31K Buy
+500
New +$34.4K ﹤0.01% 306

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CWA Asset Management Group's GILD Position: Q2 2026 in Review

CWA Asset Management Group increased its Gilead Sciences (GILD) stake by 7.2% in Q2 2026, buying an estimated $562K and bringing the position to 63,399 shares worth $8.01M. The position accounts for 0.24% of the portfolio, ranked #89.

CWA Asset Management Group first reported a position in GILD in Q4 2015 and has held it in 41 quarters since. The position peaked at $13M in Q1 2025. 911 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • CWA Asset Management Group held 63,399 shares of Gilead Sciences worth $8.01M as of Q2 2026.
  • CWA Asset Management Group bought 4,263 Gilead Sciences shares in Q2 2026, an estimated $562K.
  • Gilead Sciences made up 0.24% of CWA Asset Management Group's portfolio in Q2 2026, its #89 holding.
  • CWA Asset Management Group first reported a position in Gilead Sciences in Q4 2015 and has held it in 41 quarters since.
  • CWA Asset Management Group's Gilead Sciences position peaked at $13M in Q1 2025.
  • 911 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.